Gains and losses of CD44 expression during breast carcinogenesis and tumour progression
- 1 August 1998
- journal article
- research article
- Published by Wiley in Histopathology
- Vol. 33 (2) , 107-116
- https://doi.org/10.1046/j.1365-2559.1998.00472.x
Abstract
Aims This study was performed to investigate whether the CD44 immunophenotype of breast lesions correlates with the clinical evolution and prognosis of breast cancer. Methods and results One‐hundr...Keywords
This publication has 31 references indexed in Scilit:
- Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7–8 in human breast cancerEuropean Journal Of Cancer, 1996
- Restoration of CD44H Expression in Colon Carcinomas Reduces TumorigenicityAnnals of Surgery, 1995
- Correlation of expression of CD44 isoforms and E-cadherin with differentiation in human urothelial cell lines and transitional cell carcinomaCancer Letters, 1995
- Wet autoclave pretreatment for antigen retrieval in diagnostic immunohistochemistryThe Journal of Pathology, 1994
- Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigmCell, 1994
- Expression and modulation of CD44 variant isoforms in humansThe Journal of cell biology, 1994
- Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular originThe Journal of cell biology, 1993
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- Distinct effects of two CD44 isoforms on tumor growth in vivo.The Journal of Experimental Medicine, 1991
- A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cellsCell, 1991